Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Depression 2 Breast Neoplasms 2 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Inflammatory Breast Neoplasms 1 Constriction, Pathologic 1 Carcinoma, Hepatocellular 1 Carcinoma, Basal Cell 1 Anxiety Disorders 1

Interventions

Bevacizumab 11 atezolizumab 8 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 Nivolumab 6 durvalumab 5 tremelimumab 3 lenvatinib 3 cabozantinib 3 Ipilimumab 3 ulixertinib 2 tislelizumab 2 relatlimab 2 donafenib 2 camrelizumab 2 apatinib 2 X-Rays 2 Surgical Procedures, Operative 2 Sorafenib 2 Oxaliplatin 2 Leucovorin 2 Immunotherapy 2 Fluorouracil 2 Fluorodeoxyglucose F18 2 trifluridine tipiracil drug combination 1 trastuzumab biosimilar HLX02 1 trametinib 1 sonidegib 1 sofosbuvir-velpatasvir drug combination 1 sintilimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Therapeutics × 30 days × Clear all

NCT07628751 2026-06-05

SOCRATES HCC

University Health Network, Toronto

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡